Riskpilot← Back to searchSign inGet full accessDeepCells AB
ABActiveOrg 5568713530Knipplakullevägen 9Other software publishing · NACE 5829Est. 20112 employees
Revenue 2025
SEK 1,2M
+63% vs 2024
EBITDA margin
-31.2%
-306% vs 2024
Equity ratio
-195.8%
Financial strength
Net profit 2025
SEK -369K
-307% vs 2024
| Revenue | SEK 1,2M | +63% |
| EBITDA | SEK -369K | -306% |
| Net profit | SEK -369K | -307% |
| Total assets | SEK 143K | +11% |
| Equity | SEK -279K | -596% |
| Employees | 2 | — |
Legal name
DeepCells AB
Org number
5568713530
Legal form
Aktiebolag
NACE code
5829 · Other software publishing
Founded
9 november 2011
Share capital
SEK 59 786
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-09-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Företaget bedriver främst utveckling och försäljning för bildbehandligsmjukvara, exempelvis för analys av cellbilder. Dessutom bedrivs konsultverksamhet inom bildbehandling och självlärande mjukvara.
Address
Knipplakullevägen 9
Email
thomas.pernstal@saferadar.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 99 | 0 | 0 | 726 | 1 183 |
| Staff expenses | — | — | −58 | −806 | −1 536 |
| EBITDA | 97 | −9 | −72 | −91 | −369 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 97 | −9 | −72 | −91 | −369 |
| Net financials | — | −0 | −1 | 0 | 0 |
| Profit before tax | 97 | −9 | −73 | −91 | −369 |
| Tax | −16 | — | — | — | — |
| Net profit | 81 | −9 | −73 | −91 | −369 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 167 | 127 | 50 | 128 | 143 |
| Equity | 132 | 124 | 51 | −40 | −279 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 35 | 3 | −0 | 168 | 422 |
| Total debt | 35 | 3 | −0 | 168 | 422 |
EBITDA margin
-31.2%
This company
15.8%
Market median
-297% vs market
20212025
Equity ratio
-195.8%
This company
38.2%
Market median
-613% vs market
20212025
Return on equity
-36862000.0%
This company
18.4%
Market median
-200337057% vs market
20212025
Net profit margin
-31.1%
This company
8.1%
Market median
-484% vs market
20212025
Asset turnover
8.30×
This company
1.12×
Market median
+641% vs market
20212025
Debt / equity
1.51×
This company
0.62×
Market median
-144% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-09-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 88% | 88% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SafeRadar Research Sweden AB
DeepCells AB Board members of DeepCells AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Thomas Lars Wilhelm Pernstål | Chairman | 0 companies |
| Erik Johan Aderstedt | Deputy Board Member | 0 companies |
| Johan Henrik Degerman | Board of Directors | 0 companies |